| Authors: |
Labouesse MA; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Current address: Department of Health, Sciences and Technology, ETH Zurich, and Zurich Neuroscience Center, 8057 Zurich, Switzerland., Torres-Herraez A; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Equal second-author contribution., Chohan MO; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA.; Equal second-author contribution., Villarin J; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Equal second-author contribution., Greenwald J; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA., Sun X; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA., Zahran M; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Barnard College, Columbia University, New York, NY 10027, USA., Tang A; Columbia College, Columbia University, New York, NY 10027, USA., Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Veenstra-VanderWeele J; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA., Lacefield C; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA., Bonaventura J; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, L'Hospitalet de Llobregat, Catalonia., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.; Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore MD 21205, USA., Chan CS; Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA., Yizhar O; Departments of Brain Sciences and Molecular Neuroscience, Weizmann Institute of Science, Rehovot 76100, Israel., Kellendonk C; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA.; Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.; Lead contact: Christoph Kellendonk. |
